Vitamin E Levels during Early Iron Supplementation in Preterm Infants

ABSTRACT

On the basis of preliminary data, this larger bi-institutional continuation trial evaluating the efficacy and safety of early iron supplementation in preterm infants calls attention to the levels of vitamin E, a marker of antioxidant activity, during iron treatment. A total of 116 preterm infants were randomly assigned to receive at 2 or 4 weeks of age (n = 62, n = 54, respectively) 5 mg/kg/d of nonionic iron polymaltose complex concomitantly with a daily dose of 25 IU vitamin E (as dl-α-tocopherol acetate) from 2 weeks of age. Vitamin E (α-tocopherol) levels, iron, ferritin, hemoglobin concentration, and reticulocyte count were recorded from 2 to 8 weeks of age. The morbidities of prematurity associated with free radicals formation were also documented. A gradual increase of α-tocopherol levels within physiological range (0.8 to 3.5 mg/dL) was found in the 2-week and 4-week groups during the study period with no difference among the groups (p > 0.05 for all comparisons). At 8 weeks of age, iron and ferritin levels, hemoglobin concentration, and reticulocyte count were higher in the 2-week group. No correlation was observed between timing of both iron and vitamin E supplement and hemolysis or morbidities associated with prematurity. Thus, treatment of iron with vitamin E supplement at 2 weeks of age is, in our experience, an efficacious and safe treatment for improving anemia in preterm infants.

dl-α-tocopherol acetate, hemolysis - iron polymaltose complex - morbidities associated with prematurity - preterm infants - vitamin E

REFERENCES

• 1 Bieri J G, Farrell P M. Vitamin E.  Vitam Horm. 1976;  34 31-75
• 2 Biniwale M A, Ehrenkranz R A. The role of nutrition in the prevention and management of bronchopulmonary dysplasia.  Semin Perinatol. 2006;  30 200-208
• 3 Hill A. Intraventricular hemorrhage: emphasis on prevention.  Semin Pediatr Neurol. 1998;  5 152-160
• 4 Hittner H M, Godio L B, Rudolph A J et al.. Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants.  N Engl J Med. 1981;  305 1365-1371
• 5 Hittner H M, Rudolph A J, Kretzer F L. Suppression of severe retinopathy of prematurity with vitamin E supplementation. Ultrastructural mechanism of clinical efficacy.  Ophthalmology. 1984;  91 1512-1523
• 6 Gross S J, Landaw S A, Oski F A. Vitamin E and neonatal hemolysis.  Pediatrics. 1977;  59 995-997
• 7 Jain S K. The neonatal erythrocyte and its oxidative susceptibility.  Semin Hematol. 1989;  26 286-300
• 8 Baydas G, Karatas F, Gursu M F et al.. Antioxidant vitamin levels in term and preterm infants and their relation to maternal vitamin status.  Arch Med Res. 2002;  33 276-280
• 9 Cachia O, Leger C L, Boulot P et al.. The red blood cell vitamin E concentrations in fetuses are related to but lower than those in mothers during gestation: a possible association with maternal lipoprotein (a) plasma levels.  Am J Obstet Gynecol. 1995;  173 42-51
• 10 Desai I D, Martinez F E, Dos Santos J E, Dutra de Oliveria J E. Transient lipoprotein deficiency at birth: a cause of low levels of vitamin E in the newborn.  Acta Vitaminol Enzymol. 1984;  6 71-76
• 11 Farrell P M. Vitamin E deficiency in premature infants.  J Pediatr. 1979;  95 869-872
• 12 Williams M L, Shott R J, O'Neal P L, Oski F A. Role of dietary iron and fat on vitamin E deficiency of infancy.  N Engl J Med. 1975;  292 887-890
• 13 American Academy of Pediatrics Committee on Nutrition . Nutritional needs of low-birth-weight infants.  Pediatrics. 1985;  75 976-986
• 14 Johnson L, Quinn G E, Abbasi S et al.. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial.  J Pediatr. 1989;  114 827-838
• 15 Zipursky A, Brown E J, Watts J et al.. Oral vitamin E supplementation for the prevention of anemia in premature infants: a controlled trial.  Pediatrics. 1987;  79 61-68
• 16 Gutcher G R, Lax A A, Farrell P M. Tocopherol isomers in intravenous lipid emulsions and resultant plasma concentrations.  JPEN J Parenter Enteral Nutr. 1984;  8 269-273
• 17 Brion L P, Bell E F, Raghuveer T S. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants.  Cochrane Database Syst Rev. 2003;  4 CD003665
• 18 Melhorn D K, Gross S. Vitamin E dependent anemia in the premature infant. Effect of large doses of medicinal iron.  J Pediatr. 1971;  79 569-580
• 19 Franz A R, Mihatsch W A, Sander S, Kron M, Pohlandt F. Prospective randomized trial of early versus late enteral iron supplementation in infants with a birth weight of less than 1301 grams.  Pediatrics. 2000;  106 700-706
• 20 Arnon S, Shiff Y, Litmanovitz I et al.. The efficacy and safety of early supplementation of iron polymaltose complex in preterm infants.  Am J Perinatol. 2007;  24 95-100
• 21 Jansson L, Holmberg L, Nilsson B, Johansson B. Vitamin E requirements of preterm infants.  Acta Paediatr Scand. 1978;  67 459-463
• 22 Wright S W, Filer L J, Mason K E. Vitamin E blood levels in premature and full term infants.  Pediatrics. 1951;  7 386-393
• 23 Rao R, Georgieff M. Microminerals. In: Tsang RC, Uauy R, Koletzko B, Zlotkin S Nutrition of the Preterm Infant: Scientific Basis and Practical Guidelines. 2nd ed. Cincinnati, OH; Digital Educational Publishing 2005: 271-288
• 24 Thibeault D W. The precarious antioxidant defenses of the preterm infant.  Am J Perinatol. 2000;  17 167-181
• 25 Pathak A, Roth P, Piscitelli J, Johnson L. Role of vitamin E supplementation during erythropoietin treatment of the anemia of prematurity.  Arch Dis Child Fetal Neonatal Ed. 2003;  88 F324-F328
• 26 Gross S J, Gabriel E. Vitamin E status in preterm infants fed human milk or infant formula.  J Pediatr. 1985;  106 635-639
• 27 Mccolm J R, Fleck B W. Retinopathy of prematurity: causation.  Semin Neonatol. 2001;  6 453-460